Embryonic stem cell research halted 'due to costs'RSS Feed

A leading stem cell research company has halted its research, disappointing the many spinal cord injury patients who had put hope in the therapy.

Biotech company Geron Corp said that the costs of carrying out the embryonic stem cell research had grown too high.

The California based company was conducting the first trials of embryonic stem cell research to be approved by the US Federal drug administration.

Four people have been treated in the trial, with each injected with around two million cells.

While no new patients will be enrolled, the progress of those already treated will be tracked.

The biotech firm also announced it is cutting 38 per cent of its workforce, and will now focus on treatments for cancer.

In other news, a spinal cord injury patient has been treated with neural stem cells in a pioneering trial at Newark's StemCells Inc.

The 23-year-old German man suffered a spinal cord injury in a traffic accident and lost all sensation and mobility from the waist down.

News by Serious Law. Expert legal assistance for those affected by spinal injury

Posted by Paul Breen
 

Exoskeleton 'aids walking in spinal cord injury patients'

07 November 2011

A new device helps people with spinal cord injury to walk upright, bringing hope to those with the condition.Agnes Fejerdy, who was paralysed below the waist in a car crash, was able to take her first...

Read More...

British bobsledder Serita Shone to undergo further spinal injury surgery

04 November 2011

British Winter Olympic hopeful Serita Shone is set to undergo more surgery to correct a spinal injury sustained during a bobsleigh training session in Germany. The 22-year-old bobsleigh brakewoman has...

Read More...

Spinal injury patients in surgery 'have low vitamin D levels'

03 November 2011

Many spinal injury patients who undergo spinal fusion surgery have low levels of vitamin D, according to scientists, which could potentially delay their recovery.Orthopaedic surgeons at Washington University...

Read More...